{"id":"https://openalex.org/W7124314904","doi":"https://doi.org/10.2147/ndt.s563433","title":"Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice","display_name":"Sertraline for the Treatment of Major Depressive Disorder in the US: Effectiveness and Acceptability in Real-World Practice","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7124314904","doi":"https://doi.org/10.2147/ndt.s563433","pmid":"https://pubmed.ncbi.nlm.nih.gov/41858423","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12998965"},"language":"en","primary_location":{"id":"doi:10.2147/ndt.s563433","doi":"https://doi.org/10.2147/ndt.s563433","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s563433","pdf_url":null,"source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.2147/ndt.s563433","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056944189","display_name":"Christoph Ulrich Correll","orcid":"https://orcid.org/0000-0002-7254-5646","observed_orcids":["https://orcid.org/0000-0002-7254-5646","https://orcid.org/0000-0002-0868-4449"]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]},{"id":"https://openalex.org/I1327576362","display_name":"Feinstein Institute for Medical Research","ror":"https://ror.org/05dnene97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1302444339","https://openalex.org/I1327576362"]},{"id":"https://openalex.org/I139290212","display_name":"Hofstra University","ror":"https://ror.org/03pm18j10","country_code":"US","type":"education","lineage":["https://openalex.org/I139290212"]},{"id":"https://openalex.org/I4210106353","display_name":"Donald & Barbara Zucker School of Medicine at Hofstra/Northwell","ror":"https://ror.org/01ff5td15","country_code":"US","type":"education","lineage":["https://openalex.org/I1302444339","https://openalex.org/I139290212","https://openalex.org/I4210106353"]},{"id":"https://openalex.org/I4210166545","display_name":"Zucker Hillside Hospital","ror":"https://ror.org/05vh9vp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I4210166545"]},{"id":"https://openalex.org/I4405258522","display_name":"Deutsches Zentrum f\u00fcr Psychische Gesundheit","ror":"https://ror.org/00tkfw097","country_code":"DE","type":"nonprofit","lineage":["https://openalex.org/I4405256427","https://openalex.org/I4405258522"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE","US"],"is_corresponding":true,"raw_author_name":"Christoph Correll","raw_affiliation_strings":["Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA","Department of Child and Adolescent Psychiatry, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany","Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA","Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA","Einstein Center for Population Diversity (ECPD), Berlin, Germany","German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0002-7254-5646","affiliations":[{"raw_affiliation_string":"Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA","institution_ids":["https://openalex.org/I1327576362"]},{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]},{"raw_affiliation_string":"Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA","institution_ids":["https://openalex.org/I139290212","https://openalex.org/I4210106353"]},{"raw_affiliation_string":"Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA","institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I4210166545"]},{"raw_affiliation_string":"Einstein Center for Population Diversity (ECPD), Berlin, Germany","institution_ids":[]},{"raw_affiliation_string":"German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I4405258522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093582047","display_name":"Pradeep Purushottamahanti","orcid":"https://orcid.org/0009-0000-8001-1305","observed_orcids":["https://orcid.org/0009-0000-8001-1305"]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pradeep Purushottamahanti","raw_affiliation_strings":["Global Medical Affairs, Viatris Inc., Bangalore, India"],"raw_orcid":"https://orcid.org/0009-0000-8001-1305","affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Viatris Inc., Bangalore, India","institution_ids":["https://openalex.org/I4387153459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056286823","display_name":"Kannan Subramaniam","orcid":"https://orcid.org/0000-0001-5551-4103","observed_orcids":["https://orcid.org/0000-0001-5551-4103"]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kannan Subramaniam","raw_affiliation_strings":["Global Medical Affairs, Viatris Inc., Auckland, New Zealand"],"raw_orcid":"https://orcid.org/0000-0001-5551-4103","affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Viatris Inc., Auckland, New Zealand","institution_ids":["https://openalex.org/I4387153459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058412548","display_name":"Bituparna Bayan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bituparna Bayan","raw_affiliation_strings":["Real World Data and Analytics, Viatris Inc., Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Real World Data and Analytics, Viatris Inc., Bangalore, India","institution_ids":["https://openalex.org/I4387153459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042858283","display_name":"Joseph Cook","orcid":"https://orcid.org/0000-0001-7157-0412","observed_orcids":["https://orcid.org/0000-0001-7157-0412"]},"institutions":[{"id":"https://openalex.org/I4387153459","display_name":"Viatris","ror":"https://ror.org/01g1gvr46","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Cook","raw_affiliation_strings":["Real World Data and Analytics, Viatris Inc., Canonsburg, PA, USA"],"raw_orcid":"https://orcid.org/0000-0001-7157-0412","affiliations":[{"raw_affiliation_string":"Real World Data and Analytics, Viatris Inc., Canonsburg, PA, USA","institution_ids":["https://openalex.org/I4387153459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016131343","display_name":"Emily O. C. Palmer","orcid":"https://orcid.org/0000-0003-1190-4622","observed_orcids":["https://orcid.org/0000-0003-1190-4622"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emily Palmer","raw_affiliation_strings":["Real World Evidence, Holmusk Technologies Inc., London, UK"],"raw_orcid":"https://orcid.org/0000-0003-1190-4622","affiliations":[{"raw_affiliation_string":"Real World Evidence, Holmusk Technologies Inc., London, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134831598","display_name":"Joannas Yeow","orcid":"https://orcid.org/0000-0001-6622-2288","observed_orcids":["https://orcid.org/0000-0001-6622-2288"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joannas Yeow","raw_affiliation_strings":["Real World Evidence, Holmusk Technologies Inc., Singapore, Singapore"],"raw_orcid":"https://orcid.org/0000-0001-6622-2288","affiliations":[{"raw_affiliation_string":"Real World Evidence, Holmusk Technologies Inc., Singapore, Singapore","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069074670","display_name":"Nadia Lipunova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadia Lipunova","raw_affiliation_strings":["Real World Evidence, Holmusk Technologies Inc., London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Real World Evidence, Holmusk Technologies Inc., London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5056944189"],"corresponding_institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I1327576362","https://openalex.org/I139290212","https://openalex.org/I4210106353","https://openalex.org/I4210166545","https://openalex.org/I4405258522","https://openalex.org/I7877124"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Volume 22","issue":null,"first_page":"1","last_page":"14"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9869999885559082},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":1.0},{"id":"https://openalex.org/keywords/antidepressant-discontinuation","display_name":"antidepressant discontinuation","score":0.8059999942779541},{"id":"https://openalex.org/keywords/treatment-acceptability","display_name":"treatment acceptability","score":0.8309999704360962},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.9369999766349792},{"id":"https://openalex.org/keywords/cardiovascular-comorbidity","display_name":"cardiovascular comorbidity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/diabetes-comorbidity","display_name":"diabetes comorbidity","score":0.9959999918937683},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.7289999723434448},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8420000076293945},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.6600000262260437},{"id":"https://openalex.org/keywords/routine-clinical-practice","display_name":"routine clinical practice","score":0.6019999980926514},{"id":"https://openalex.org/keywords/sex-differences-in-treatment-response","display_name":"sex differences in treatment response","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.9498000144958496},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.9333000183105469},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8884000182151794},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.7623000144958496},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5408999919891357},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.47909998893737793},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.4397999942302704},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4189999997615814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.415800005197525},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.40209999680519104},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.39649999141693115},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.36890000104904175},{"id":"https://openalex.org/C134362201","wikidata":"https://www.wikidata.org/wiki/Q317309","display_name":"Mental health","level":2,"score":0.30559998750686646},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.2955000102519989},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.288100004196167},{"id":"https://openalex.org/C3019858935","wikidata":"https://www.wikidata.org/wiki/Q4340209","display_name":"Depressive symptoms","level":3,"score":0.28700000047683716},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2736999988555908},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.26969999074935913},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.2680000066757202},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2662999927997589},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.250900000333786}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/ndt.s563433","doi":"https://doi.org/10.2147/ndt.s563433","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s563433","pdf_url":null,"source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12998965","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12998965/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12998965/pdf/NDT-22-563433.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatr Dis Treat","raw_type":"Text"},{"id":"pmid:41858423","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41858423","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric disease and treatment","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/111049","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/sertraline-for-the-treatment-of-major-depressive-disorder-in-the-us-ef-peer-reviewed-fulltext-article-NDT","pdf_url":"https://www.dovepress.com/article/download/111049","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:c043049cf7124e1baec015aa0387e3b1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c043049cf7124e1baec015aa0387e3b1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Neuropsychiatric Disease and Treatment, Vol Volume 22, Iss Issue 1, Pp 1-14 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.2147/ndt.s563433","doi":"https://doi.org/10.2147/ndt.s563433","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ndt.s563433","pdf_url":null,"source":{"id":"https://openalex.org/S124245730","display_name":"Neuropsychiatric Disease and Treatment","issn_l":"1176-6328","issn":["1176-6328","1178-2021"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychiatric Disease and Treatment","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7124314904.pdf","grobid_xml":"https://content.openalex.org/works/W7124314904.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W179669856","https://openalex.org/W1518815626","https://openalex.org/W1608367062","https://openalex.org/W1609635846","https://openalex.org/W1742833546","https://openalex.org/W1904816587","https://openalex.org/W1951131186","https://openalex.org/W1966841478","https://openalex.org/W1984615306","https://openalex.org/W2010163603","https://openalex.org/W2030799847","https://openalex.org/W2037983891","https://openalex.org/W2058761478","https://openalex.org/W2060673642","https://openalex.org/W2071000148","https://openalex.org/W2097950056","https://openalex.org/W2102160051","https://openalex.org/W2106104254","https://openalex.org/W2131777148","https://openalex.org/W2137296158","https://openalex.org/W2150458484","https://openalex.org/W2158245987","https://openalex.org/W2163383855","https://openalex.org/W2172129050","https://openalex.org/W2414864695","https://openalex.org/W2564988627","https://openalex.org/W2568301711","https://openalex.org/W2613459819","https://openalex.org/W2788337440","https://openalex.org/W2789034326","https://openalex.org/W2904026243","https://openalex.org/W2976277449","https://openalex.org/W2995605526","https://openalex.org/W3048087059","https://openalex.org/W3088319616","https://openalex.org/W3092849554","https://openalex.org/W3107674131","https://openalex.org/W3113178943","https://openalex.org/W3148670629","https://openalex.org/W3172917326","https://openalex.org/W3192405604","https://openalex.org/W3196783567","https://openalex.org/W3204219363","https://openalex.org/W3205507803","https://openalex.org/W4211263234","https://openalex.org/W4224308601","https://openalex.org/W4241803515","https://openalex.org/W4252553827","https://openalex.org/W4317772061","https://openalex.org/W4381799391","https://openalex.org/W4388972558","https://openalex.org/W4396699590","https://openalex.org/W4401241477","https://openalex.org/W4402564798","https://openalex.org/W4404141179","https://openalex.org/W4405085132"],"related_works":["https://openalex.org/W4414180456","https://openalex.org/W2112856387","https://openalex.org/W2042231113","https://openalex.org/W1966841478","https://openalex.org/W2409265367","https://openalex.org/W1965331095","https://openalex.org/W169985848","https://openalex.org/W7120574771","https://openalex.org/W2573246497","https://openalex.org/W2003982537"],"abstract_inverted_index":{"Background:":[0],"Major":[1,303],"depressive":[2,304,467,546],"disorder":[3,305],"(MDD)":[4,306],"is":[5,16,37,46,307,331,399],"a":[6,32,97,308,332,401,432],"serious":[7,309],"mental":[8],"illness":[9,238,468,493],"and":[10,27,40,45,60,117,127,134,144,149,280,298,328,398,409,444,481],"leading":[11],"cause":[12],"of":[13,62,184,226,275,283,345,356,403,425,466],"disability.":[14],"MDD":[15,112,288,318,361,443,506],"highly":[17],"comorbid":[18,114,292],"with":[19,87,109,115,119,148,228,236,261,287,289,317,360,373,423,442,487,490,501,505,513],"physical":[20],"illnesses":[21,295,446],"such":[22,324],"as":[23,96,325,454,460],"cardiovascular":[24],"disease":[25,327,449],"(CVD)":[26],"diabetes":[28,451],"mellitus":[29],"(DM).":[30],"Sertraline,":[31],"selective":[33],"serotonin":[34],"reuptake":[35],"inhibitor,":[36],"proven":[38],"effective":[39],"well-tolerated":[41],"in":[42,64,77,89,105,155,159,190,216,222,256,285,342,363,472,507],"clinical":[43,66,262,281],"trials,":[44],"recommended":[47],"among":[48],"first-line":[49],"treatment":[50,267,335,372,512],"options":[51],"for":[52,111,165,336,395,527],"MDD.":[53],"Methods:":[54],"This":[55,249,350,386],"study":[56,250,351,421,509],"explored":[57],"the":[58,78,84,273,343,353,364,406,420,536],"effectiveness":[59,279],"acceptability":[61],"sertraline":[63,81,110,178,266,284,394,418,459,480],"real-world":[65,278,548],"practice,":[67],"utilizing":[68],"electronic":[69],"health":[70,310,322,348],"record-derived,":[71],"de-identified":[72],"data":[73,164,519],"from":[74,371,520],"NeuroBlu":[75],"Data":[76],"USA.":[79],"All-cause":[80,101],"discontinuation":[82,102,123,254,384],"was":[83,103,157,379,381,412,469],"main":[85,376],"outcome,":[86],"change":[88],"Clinical":[90,540],"Global":[91,541],"Impressions":[92],"Severity":[93],"(CGI-S)":[94],"serving":[95],"secondary":[98],"outcome.":[99],"Results:":[100],"assessed":[104,158],"2948":[106],"patients":[107,161,185,286,504],"treated":[108,500],"(702":[113],"CVD":[116,151,297],"280":[118],"DM).":[120],"The":[121,269,375,463],"cumulative":[122],"rates":[124,255],"at":[125,240,388,438],"2-":[126],"3-month":[128],"follow-up":[129,169,197],"time":[130,198],"points":[131],"were":[132,140,242,259,452,485,494],"16.9%":[133],"24.8%,":[135],"respectively.":[136],"No":[137],"significant":[138],"differences":[139],"observed":[141,486],"between":[142,172],"males":[143],"females":[145],"or":[146,152,167,206,290,450],"those":[147,461],"without":[150,291],"DM.":[153,299],"Change":[154],"CGI-S":[156,191,217],"713":[160],"who":[162],"had":[163,435],"one":[166],"more":[168,243,491,495,530],"assessments":[170],"conducted":[171],"2":[173,430],"to":[174,182,202,224,230,245,272,366,456,497,511,534],"24":[175],"months":[176],"after":[177,429],"prescription.":[179],"About":[180],"9%":[181],"17%":[183,424],"demonstrated":[186],"clinically":[187,213],"substantial":[188],"improvement":[189,215],"(decrease":[192,218],"by":[193,219],"\u2265":[194,220],"2)":[195],"across":[196],"points,":[199],"while":[200],"74%":[201],"88%":[203],"showed":[204,212],"little":[205],"no":[207,233],"change.":[208,234],"A":[209],"sensitivity":[210],"analysis":[211],"meaningful":[214],"1)":[221],"19%":[223],"36%":[225],"patients,":[227],"54%":[229],"69%":[231],"showing":[232],"Patients":[235,489],"greater":[237],"severity":[239,465],"baseline":[241],"likely":[244,455,496],"experience":[246],"improvement.":[247],"Conclusion:":[248],"demonstrates":[251],"that":[252,523],"all-cause":[253],"routine":[257],"practice":[258],"consistent":[260],"trials":[263],"indicating":[264],"comparable":[265],"acceptability.":[268],"findings":[270],"add":[271],"body":[274],"evidence":[276],"on":[277],"utility":[282],"chronic":[293],"medical":[294,354,521],"like":[296,447],"Plain":[300],"Language":[301],"Summary:":[302],"condition":[311],"affecting":[312],"many":[313,390],"people":[314,391,415,426,474],"worldwide.":[315],"People":[316,441],"often":[319],"have":[320,524],"other":[321,347,445,528],"problems":[323],"heart":[326,448],"diabetes.":[329],"Sertraline":[330],"commonly":[333],"used":[334,352],"MDD,":[337],"which":[338],"may":[339],"be":[340],"prescribed":[341],"presence":[344],"these":[346],"issues.":[349],"records":[355,522],"about":[357],"3000":[358],"adults":[359],"living":[362],"US":[365],"explore":[367],"whether":[368],"they":[369,477],"benefitted":[370],"sertraline.":[374,502,514],"way":[377],"this":[378,508],"measured":[380],"using":[382],"\u201call-cause":[383],"rate\u201d.":[385],"looks":[387],"how":[389,404,410],"stopped":[392,436],"taking":[393,417,458,479],"any":[396],"reason":[397],"considered":[400],"measure":[402],"well":[405],"medicine":[407],"worked":[408],"it":[411,428,437],"tolerated.":[413],"Most":[414],"continued":[416],"during":[419],"period,":[422],"stopping":[427],"months;":[431],"further":[433],"8%":[434],"3":[439],"months.":[440],"just":[453],"keep":[457],"without.":[462],"overall":[464],"not":[470],"high":[471],"most":[473],"studied":[475],"when":[476,499,516],"started":[478],"only":[482],"small":[483],"changes":[484],"treatment.":[488],"severe":[492],"improve":[498],"Overall,":[503],"responded":[510],"However,":[515],"studies":[517,531],"use":[518],"been":[525],"collected":[526],"reasons,":[529],"are":[532],"needed":[533],"confirm":[535],"results.":[537],"Keywords:":[538],"antidepressants,":[539],"Impression":[542],"\u2013":[543],"Severity,":[544],"major":[545],"disorder,":[547],"evidence,":[549],"sertraline,":[550],"United":[551],"States":[552]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-01-16T00:00:00"}